Company / SG&A Expense
HARVARD BIOSCIENCE INC SG&A Expense History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A Expense
$21.5M
FY2025
5-year range
$21.5M / $24.5M
FY2021-FY2025
Trend
-5.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
SG&A Expense has fluctuated over the past 10 years, ranging from $17M in FY2016 to $24M in FY2023.
Based on SEC 10-K filings.
$21M in FY2025 with a 5-year CAGR of -1.1%.
Improved from $24M to $21M over the past 2 years.
SG&A Expense over time
Growth rates
- 3-Year CAGR
- -4.0%
- 5-Year CAGR
- -1.1%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -1.1%, indicating a declining trend.
- In FY2025, sg&a expense decreased 5.6% year-over-year.
- Peak sg&a expense was recorded in FY2023.
- Lowest sg&a expense in the period was in FY2016.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $21.5M | -5.6% |
| FY2024 | $22.8M | -7.1% |
| FY2023 | $24.5M | +0.8% |
| FY2022 | $24.3M | +3.4% |
| FY2021 | $23.5M | +3.3% |
| FY2020 | $22.8M | +6.4% |
| FY2019 | $21.4M | +22.0% |
| FY2018 | $17.5M | -11.6% |
| FY2017 | $19.8M | +17.9% |
| FY2016 | $16.8M | -5.9% |
As of FY2025 · SEC 10-K Annual Filings · Updated Jun 24, 2026